Likewise, Deoxyribonuclease 1 (DNase1) has been shown to safely degrade NETs across various murine models, including breast cancer, pulmonary inflammation, and autoimmune diseases, with no significant toxicity reported in non-cancer clinical use [122]. This evidence concerns the gene DNASE1 and breast carcinoma.